KCM
VIVO

Kennedy Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Kennedy Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-557,480
Closed -$9.47M – 715
2020
Q3 		$9.47M Sell
557,480
-11,721
-2% -$228K 0.27% 103
2020
Q2 		$13.3M Buy
569,201
+151,849
+36% +$2.2M 0.38% 42
2020
Q1 		$3.51M Buy
+417,352
New +$3.51M 0.13% 301
2017
Q2 		– Sell
-141,612
Closed -$1.95M – 764
2017
Q1 		$1.95M Buy
+141,612
New +$1.98M 0.03% 595

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kennedy Capital Management's VIVO Position: Q4 2020 in Review

Kennedy Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q4 2020, closing a stake of 557,480 shares — an estimated $9.47M sold.

Kennedy Capital Management first reported a position in VIVO in Q1 2017 and held it in 4 quarters. The position peaked at $13.3M in Q2 2020. 192 funds tracked by Wall St. Rank hold VIVO as of Q4 2020.

  • Kennedy Capital Management reported no remaining Meridian Bioscience Inc position as of Q4 2020 after selling out during the quarter.
  • Kennedy Capital Management sold 557,480 Meridian Bioscience Inc shares in Q4 2020, an estimated $9.47M.
  • Kennedy Capital Management first reported a position in Meridian Bioscience Inc in Q1 2017 and held it in 4 quarters.
  • Kennedy Capital Management's Meridian Bioscience Inc position peaked at $13.3M in Q2 2020.
  • 192 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2020.

Based on Kennedy Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.